These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4058978)

  • 1. The short child with subnormal plasma somatomedin C.
    Rudman D; Kutner MH; Chawla RK
    Pediatr Res; 1985 Oct; 19(10):975-80. PubMed ID: 4058978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Children with normal-variant short stature: treatment with human growth hormone for six months.
    Rudman D; Kutner MH; Blackston RD; Cushman RA; Bain RP; Patterson JH
    N Engl J Med; 1981 Jul; 305(3):123-31. PubMed ID: 7195462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: response to exogenous growth hormone.
    Bright GM; Rogol AD; Johanson AJ; Blizzard RM
    Pediatrics; 1983 Apr; 71(4):576-80. PubMed ID: 6340044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation.
    Plotnick LP; Van Meter QL; Kowarski AA
    Pediatrics; 1983 Mar; 71(3):324-7. PubMed ID: 6681897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of growth hormone in the nocturnal serum of children.
    Rudman D; Chawla RK; Kutner MH
    Pediatr Res; 1985 Oct; 19(10):981-5. PubMed ID: 3932952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa.
    Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G
    Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone treatment for short stature.
    Van Vliet G; Styne DM; Kaplan SL; Grumbach MM
    N Engl J Med; 1983 Oct; 309(17):1016-22. PubMed ID: 6684729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Somatomedins].
    Ranke MB; Blum W; Bierich JR
    Wien Klin Wochenschr; 1987 May; 99(9):306-12. PubMed ID: 3604213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
    Kastrup KW; Andersen H; Eskildsen PC; Jacobsen BB; Krabbe S; Petersen KE
    Acta Paediatr Scand Suppl; 1979; 277():8-13. PubMed ID: 396757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-1 and IGFBP-3 screening for disorders of growth hormone secretion.
    Rasat R; Livesey JL; Espiner EA; Abbott GD; Donald RA
    N Z Med J; 1996 May; 109(1021):156-9. PubMed ID: 8657365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
    Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
    J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [IGFBP3 in the assessment of growth hormone defects].
    Sposito M; Truffarelli F; Sabalich I; De Giorgi G; Cova L; Britta R; Rufini S
    Pediatr Med Chir; 1993; 15(1):67-71. PubMed ID: 7683813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dwarfism in the Alagille syndrome caused by somatomedin C deficiency?].
    Blümel P; Sacher M; Paky F; Stögmann W
    Padiatr Padol; 1986; 21(3):257-64. PubMed ID: 3095769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in specific binding of insulin-like growth factor (IGF) II to type 1 IGF receptors on erythrocytes of hypopituitary children receiving growth hormone therapy.
    Costigan CD; Polychronakos C; Guyda HJ; Posner BI
    Clin Invest Med; 1988 Feb; 11(1):47-51. PubMed ID: 2966692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of somatomedin C by cartridge extraction prior to radioimmunoassay with antiserum developed against synthetic somatomedin C.
    Kao PC; Tateishi K; Abboud CF; Zimmerman D; Randall RV; Li CH
    Ann Clin Lab Sci; 1988; 18(2):120-30. PubMed ID: 2454603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factors I and II in evaluation of growth retardation.
    Rosenfeld RG; Wilson DM; Lee PD; Hintz RL
    J Pediatr; 1986 Sep; 109(3):428-33. PubMed ID: 3746530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatomedin C in pediatric pathophysiology.
    Cacciari E; Cicognani A
    Pediatrician; 1987; 14(3):146-53. PubMed ID: 3453495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian rhythm in plasma immunoreactive somatomedin-C in children.
    Nicolau GY; Haus E; Lakatua D; Plîngă L; Sackett-Lundeen L; Berg H; Ungureanu E; Petrescu E
    Endocrinologie; 1985; 23(2):97-103. PubMed ID: 4041074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and somatomedin responses to growth hormone in Down's syndrome.
    Annerén G; Sara VR; Hall K; Tuvemo T
    Arch Dis Child; 1986 Jan; 61(1):48-52. PubMed ID: 2937371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of human growth hormone administration on serum somatomedins, somatomedin carrier proteins, and growth rates in children with growth hormone deficiency.
    Schalch DS; Tollefsen SE; Klingensmith GJ; Gotlin RW; Diehl MJ
    J Clin Endocrinol Metab; 1982 Jul; 55(1):49-55. PubMed ID: 6176592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.